| Chapter title |
Mammalian Cell Cultures for Biologics Manufacturing.
|
|---|---|
| Chapter number | 255 |
| Book title |
Mammalian Cell Cultures for Biologics Manufacturing
|
| Published in |
Advances in biochemical engineering biotechnology, November 2013
|
| DOI | 10.1007/10_2013_255 |
| Pubmed ID | |
| Book ISBNs |
978-3-64-254049-3, 978-3-64-254050-9
|
| Authors |
Kantardjieff A, Zhou W, Anne Kantardjieff, Weichang Zhou, Kantardjieff, Anne, Zhou, Weichang |
| Abstract |
Biopharmaceuticals represent a growing sector of the pharmaceutical industry, and are used for a wide range of indications, including oncology and rheumatology. Cultured mammalian cells have become the predominant expression system for their production, partly due to their ability to complete the posttranslational modifications required for drug safety and efficacy. Over the past decade, the productivity of mammalian cell culture production processes has growth dramatically through improvements in both volumetric and specific productivities. This article presents an overview of the biologics market, including analysis of sales and approvals; as well as a review of industrial production cell lines and cell culture operations. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | <1% |
| India | 1 | <1% |
| Iran, Islamic Republic of | 1 | <1% |
| Belgium | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 217 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 44 | 20% |
| Student > Master | 43 | 19% |
| Researcher | 27 | 12% |
| Student > Bachelor | 25 | 11% |
| Other | 9 | 4% |
| Other | 12 | 5% |
| Unknown | 62 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 55 | 25% |
| Biochemistry, Genetics and Molecular Biology | 38 | 17% |
| Engineering | 28 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 6% |
| Chemical Engineering | 9 | 4% |
| Other | 17 | 8% |
| Unknown | 62 | 28% |